Evidence map›Paper›PMID 25142911›Full record

ArticleBMC neuroscience2014

Simultaneous monitoring of cerebral metal accumulation in an experimental model of Wilson's disease by laser ablation inductively coupled plasma mass spectrometry.

Sorina Georgiana Boaru, Uta Merle, Ricarda Uerlings, Astrid Zimmermann, Sabine Weiskirchen, Andreas Matusch, Wolfgang Stremmel, Ralf Weiskirchen

Open access · goldAbstract read
In one paragraph

Article in BMC neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Animal models of Wilson disease.Journal of neurochemistry · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Manganese Is Essential for Neuronal Health.Annual review of nutrition · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sorina Georgiana Boaru
Uta Merle
Ricarda Uerlings
Astrid Zimmermann
Sabine Weiskirchen
Andreas Matusch
Wolfgang Stremmel
Ralf WeiskirchenInstitute of Clinical Chemistry and Pathobiochemistry, RWTH Aachen University Hospital Aachen, Pauwelsstr, 30, D-52074 Aachen, Germany. rweiskirchen@ukaachen.de.
Heidelberg University · DERWTH Aachen University · DEUniversitätsklinikum Aachen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeuropsychiatric affection involving extrapyramidal symptoms is a frequent component of Wilson's disease (WD). WD is caused by a genetic defect of the copper (Cu) efflux pump ATPase7B. Mouse strains with natural or engineered transgenic defects of the Atp7b gene have served as model of WD. These show a gradual accumulation and concentration of Cu in liver, kidneys, and brain. However, still little is known about the regional distribution of Cu inside the brain, its influence on other metals and subsequent pathophysiological mechanisms. We have applied laser ablation inductively coupled plasma mass spectrometry and performed comparative metal bio-imaging in brain sections of wild type and Atp7b null mice in the age range of 11-24 months. Messenger RNA and protein expression of a panel of inflammatory markers were assessed using RT-PCR and Western blots of brain homogenates.

resultsWe could confirm Cu accumulation in brain parenchyma by a factor of two in WD (5.5 μg g(-1) in the cortex) vs. controls (2.7 μg g(-1)) that was already fully established at 11 months. In the periventricular regions (PVR) known as structures of prominent Cu content, Cu was reduced in turn by a factor of 3. This corroborates the view of the PVR as efflux compartments with active transport of Cu into the cerebrospinal fluid. Furthermore, the gradient of Cu increasing downstream the PVR was relieved. Otherwise the architecture of Cu distribution was essentially maintained. Zinc (Zn) was increased by up to 40% especially in regions of high Cu but not in typical Zn accumulator regions, a side effect due to the fact that Zn is to some degree a substrate of Cu-ATPases. The concentrations of iron (Fe) and manganese (Mn) were constant throughout all regions assessed. Inflammatory markers TNF-α, TIMP-1 and the capillary proliferation marker α-SMA were increased by a factor of 2-3 in WD.

conclusionsThis study confirmed stable cerebral Cu accumulation in parenchyma and discovered reduced Cu in cerebrospinal fluid in Atp7b null mice underlining the diagnostic value of micro-local analytical techniques.

Indexed as

ActinsAdenosine TriphosphatasesAgingAnimalsBlotting, WesternBrainCation Transport ProteinsCopperCopper-Transporting ATPasesDisease Models, AnimalDisease ProgressionHepatolenticular DegenerationIronLaser TherapyManganeseMass SpectrometryActinsAdenosine Triphosphatasesalpha-smooth muscle actin, mouseAtp7a protein, mouseCation Transport ProteinsCopperCopper-Transporting ATPasesIronManganeseRNA, MessengerTimp1 protein, mouseTissue Inhibitor of Metalloproteinase-1Tumor Necrosis Factor-alphaZinc

Identifiers

PMID25142911
PMCPMC4156608
OpenAlexW2048684729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.